83. Addison disease
20 clinical trials,   42 drugs   (DrugBank: 13 drugs),   6 drug target genes,   17 drug target pathways
Searched query = "Addison disease", "Primary chronic adrenocortical insufficiency", "Autoimmune polyglandular syndrome", "Hypoparathyroidism-Addison-Monilia syndrome", "HAM syndrome", "Schmidt syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00004313 (ClinicalTrials.gov) | August 1995 | 18/10/1999 | Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency | Addison's Disease | Drug: dehydroepiandrosterone | National Center for Research Resources (NCRR) | University of California, Los Angeles | Completed | 18 Years | N/A | Both | 40 | Phase 3 | NULL |